MOC
Available: 12/08/2023-07/31/2026
Format
This course will meet the new government-mandated requirement for all DEA-registered practitioners to complete eight hours of training on the treatment and management of patients with opioid or other substance use disorders prior to applying for or renewing their license.
Pain in pediatric patients is common, under-recognized, and undertreated. Unrelieved acute, chronic, and needle pain in childhood directly results in poorer clinical outcomes, including increased morbidity, degree of anxiety, needle-phobia, health care avoidance, and chronic pain, which may contribute to substance use disorders.
Focused on pediatrics, this online course addresses pain management and opioid state medical board CME requirements. It also meets the new DEA requirements, found in the Medication Access and Training Expansion (MATE) Act, to complete eight hours of training on the treatment and management of patients with opioid or other substance use disorders prior to applying for or renewing their license.
Developed for general pediatricians, pediatric subspecialists, other pediatric clinicians, and allied health professionals, this evidence-based course includes clinical content and question-and-answer sessions from the AAP’s 2023 Acute and Chronic Pain course.
By participating in this CME activity, you will be able to:
Managing Acute and Chronic Pain and Substance Use Disorders in Pediatrics Update |
|
Recording |
Faculty |
How to use Hypnotic Language and Hypnosis in your Pediatric Practice to treat pain and anxiety |
David K. Becker, MD, LMFT, FAAP |
Adverse Childhood Experiences and Pediatric Pain |
Cristina Benki, PhD |
Primary Pain Disorders: Headaches, Tummy Pain, and Sore Muscles/Joints: Red Flags for Further Workup, Evidence of "Preventatives" and other Pharmacology, Effective Treatment Strategies |
William E. Bernal, MD, MPH |
Simple Analgesia? Acetaminophen, NSAIDs and Cox-2 Inhibitors |
David A. Burns, MD |
Opioid Selection and Safe Prescribing in Pediatrics: Discussing Possible Risks With Every Family |
Deepa Camenga, MD, MHS, FAAP |
What is Pain in Children: I Know it When I see it? |
Stefan J. Friedrichsdorf, MD, FAAP |
Treatment of Opioid Use Disorder |
Lucien Gonzalez, MD, MS, FAAP |
Opioids in Pediatrics: Indications and Contra-indications |
Stephen R. Hays, MD, FAAP |
Sickle-Cell Pain: Acute and Chronic Pain Treatment and Prevention |
Claudia R. Morris, MD, FAAP |
Pain in a Child with Developmental Disability: What to do When your Pain Treatment Doesn't Seem to Work |
Tim Oberlander, MD |
Cannabis and Cannabinoids for Acute, Chronic and Neuropathic Pain Treatment: What is the Evidence Regarding Safety and Efficacy? |
Andrew S. C. Rice, MD, FRCP, FRCA, FFPMRCA, FFPMCAI |
Moving Along? Exercise and Physical Therapy in Pediatric Pain Treatment |
Michael Sangster, BScPT, DPT |
Chronic Pain = Real Pain and Not Just in Your Head! The Broken-Car-Alarm and Other Metaphors: How to Explain Chronic Pain to Parents and Patients (and avoid further testing) |
Neil L. Schechter, MD, FAAP; Dr. Wilder |
Opioid Rotation in Kids: Equianalgesic from Coke to Pepsi? |
Scott A. Schwantes, MD, FAAHPM, FAAP |
Substance Use Disorder in Pediatrics: Introduction to Screening and Treatment Options |
Christine B. Sieberg, PhD, EdM, MA |
Multimodal Analgesia: Better Pain Control with Fewer Side Effects |
Karen I. Sun, MD |
Implicit Bias and its Consequences on Pediatric Pain Management |
Marsha Treadwell, PhD |
The Elephant in the Room - Appropriate Analgesia in the Time of an Opioid Epidemic |
Gary A. Walco, PhD, ABPP |
Faculty (Subject Matter Experts)
David K. Becker, MD, LMFT, FAAP
Cristina Benki, PhD
William E. Bernal, MD, MPH
David A. Burns, MD
Deepa Camenga, MD, MHS, FAAP
Stefan J. Friedrichsdorf, MD, FAAP
Lucien Gonzalez, MD, MS, FAAP
Stephen R. Hays, MD, FAAP
Claudia R. Morris, MD, FAAP
Tim F. Oberlander, MD
Andrew S.C. Rice, MD, FRCP, FRCA, FFPMRCA, FFPMCAI
Michael Sangster, BScPT, DPT
Neil L. Schechter, MD, FAAP
Scott A. Schwantes, MD, FAAHPM, FAAP
Christine B. Sieberg, PhD, EdM, MA
Karen I. Sun, MD
Marsha Treadwell, PhD
Gary A. Walco, PhD, ABPP
Planning Group
Stefan Friedrichsdorf, MD, FAAP - Chair
Lucien Gonzalez, MD, MS, FAAP
Hilary M. Haftel, MD, MHPE, FAAP
Robert Wilder, MD, PhD, FAAP
AAP Medical Student Member - $120
AAP Resident Member - $120
AAP Fellow in Training Member - $120
AAP Pediatrician/Fellow Member - $185
National Afffiliate Member - $155
Individual Non-Member - $240
Enduring Materials
AAP Credit
NAPNAP Contact Hours
MOC Part 2
AAPA Credit Hours
Physician - Managing Acute and Chronic Pain and Substance Use Disorders in Pediatrics Update
The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AAP designates this enduring material for a maximum of 10.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is acceptable for a maximum of 10.00 AAP credits. These credits can be applied toward the AAP CME/CPD Award available to Fellows and Candidate Members of the AAP.
This activity is approved for 10.00 points of MOC Part 2 credit by the American Board of Pediatrics through the AAP MOC Portfolio Program. All approved activities must be completed by the MOC Credit Approval End Date. All deadlines and MOC point values should be confirmed by checking the ABP Activity Catalog within each physician’s ABP Portfolio. Consult your ABP portfolio at www.abp.org for details about your specific certification requirements. For questions about how to access this activity, contact MOCPortfolio@aap.org.
The American Academy of Pediatrics (AAP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
PAs may claim a maximum of 10.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
This program is accredited for 10.00 NAPNAP CE contact hours of which 0.00 contain pharmacology (Rx) content, (0.00 related to psychopharmacology) (0.00 related to controlled substances), per the National Association of Pediatric Nurse Practitioners (NAPNAP) Continuing Education Guidelines. The AAP is designated as Agency #A17. Upon completion of the program, each participant desiring NAPNAP contact hours must send a completed certificate of attendance to ce@napnap.org. Payment of $15 for NAPNAP members and nonmembers is required via credit card for all NAPNAP contact hour requests. Keep this certificate for your records for six (6) years. Requests for duplicate certificates should be made to the AAP.
Recommended Browsers:
Recommended Browser Settings:
Price:: 240.00